Literature DB >> 22795189

Association between sarcopenia and higher-level functional capacity in daily living in community-dwelling elderly subjects in Japan.

Yoshimi Tanimoto1, Misuzu Watanabe, Wei Sun, Yumiko Sugiura, Yuko Tsuda, Motoshi Kimura, Itsushi Hayashida, Toshiyuki Kusabiraki, Koichi Kono.   

Abstract

This study aimed to determine the association between sarcopenia, defined by muscle mass, muscle strength, and physical performance, and higher-level functional capacity in community-dwelling Japanese elderly people. Subjects were 1158 elderly, community-dwelling Japanese people aged 65 or older. We used bioelectrical impedance analysis to measure muscle mass, grip strength to measure muscle strength, and usual walking speed to measure physical performance. Sarcopenia was characterized by low muscle mass, plus low muscle strength or low physical performance. Subjects without low muscle mass, low muscle strength, and low physical performance were classified as "normal." Examination of higher-level functional capacity was performed using the Tokyo Metropolitan Institute of Gerontology Index of Competence (TMIG-IC). The TMIG-IC is a 13-item questionnaire completed by the subject; it contains five questions on self-maintenance and four questions each on intellectual activity and social role. Sarcopenia was identified in 11.3% and 10.7% of men and women, respectively. The percentage of disability for instrumental activities of daily living (IADL) was 39.0% in men with sarcopenia and 30.6% in women with sarcopenia. After adjustment for age, in men, sarcopenia was significantly associated with IADL disability compared with intermediate and normal subjects. In women, sarcopenia was significantly associated with every subscale of the TMIG-IC disability compared with intermediate and normal subjects. This study revealed that sarcopenia, defined by muscle mass, muscle strength, and physical performance, had a significant association with disability in higher-level functional capacity in elderly Japanese subjects. Interventions to prevent sarcopenia may prevent higher-level functional disability among elderly people.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22795189     DOI: 10.1016/j.archger.2012.06.015

Source DB:  PubMed          Journal:  Arch Gerontol Geriatr        ISSN: 0167-4943            Impact factor:   3.250


  70 in total

1.  Prevalence of sarcopenic obesity in Germany using established definitions: Baseline data of the FORMOsA study.

Authors:  W Kemmler; S von Stengel; K Engelke; C Sieber; E Freiberger
Journal:  Osteoporos Int       Date:  2015-08-29       Impact factor: 4.507

2.  Prevalence and co-existence of locomotive syndrome, sarcopenia, and frailty: the third survey of Research on Osteoarthritis/Osteoporosis Against Disability (ROAD) study.

Authors:  Noriko Yoshimura; Shigeyuki Muraki; Toshiko Iidaka; Hiroyuki Oka; Chiaki Horii; Hiroshi Kawaguchi; Toru Akune; Kozo Nakamura; Sakae Tanaka
Journal:  J Bone Miner Metab       Date:  2019-06-20       Impact factor: 2.626

3.  Effects of Aerobic and Resistance Training Combined with Fortified Milk on Muscle Mass, Muscle Strength, and Physical Performance in Older Adults: A Randomized Controlled Trial.

Authors:  Y Osuka; S Fujita; N Kitano; K Kosaki; J Seol; Y Sawano; H Shi; Y Fujii; S Maeda; T Okura; H Kobayashi; K Tanaka
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

4.  Effectiveness of Cardiac Rehabilitation for Prevention and Treatment of Sarcopenia in Patients with Cardiovascular Disease - A Retrospective Cross-Sectional Analysis.

Authors:  H Harada; H Kai; H Niiyama; Y Nishiyama; A Katoh; N Yoshida; Y Fukumoto; H Ikeda
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

5.  Letter to the editor: Normative data of handgrip strength in 26344 older adults - a pooled dataset from eight cohorts in Asia.

Authors:  T W Auyeung; H Arai; L K Chen; J Woo
Journal:  J Nutr Health Aging       Date:  2020       Impact factor: 4.075

6.  Is osteoporosis a predictor for future sarcopenia or vice versa? Four-year observations between the second and third ROAD study surveys.

Authors:  N Yoshimura; S Muraki; H Oka; T Iidaka; R Kodama; H Kawaguchi; K Nakamura; S Tanaka; T Akune
Journal:  Osteoporos Int       Date:  2016-11-24       Impact factor: 4.507

Review 7.  Managing sarcopenia and its related-fractures to improve quality of life in geriatric populations.

Authors:  Tetsuro Hida; Atsushi Harada; Shiro Imagama; Naoki Ishiguro
Journal:  Aging Dis       Date:  2013-11-26       Impact factor: 6.745

8.  Factors that characterize bone health with aging in healthy postmenopausal women.

Authors:  Shota Ikegami; Shigeharu Uchiyama; Yukio Nakamura; Keijiro Mukaiyama; Hiroki Hirabayashi; Mikio Kamimura; Kiichi Nonaka; Hiroyuki Kato
Journal:  J Bone Miner Metab       Date:  2014-08-12       Impact factor: 2.626

Review 9.  Effect of Angiotensin-Converting Enzyme Inhibitors on Physical Function in Elderly Subjects: A Systematic Review and Meta-Analysis.

Authors:  Ling-shan Zhou; Ling-jie Xu; Xue-qing Wang; Yi-huan Huang; Qian Xiao
Journal:  Drugs Aging       Date:  2015-09       Impact factor: 3.923

10.  Prevalence of site-specific thigh sarcopenia in Japanese men and women.

Authors:  Takashi Abe; Robert S Thiebaud; Jeremy P Loenneke; Mark Loftin; Tetsuo Fukunaga
Journal:  Age (Dordr)       Date:  2013-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.